133 / 154
459
cancer patients: The role of pain, cancer type and treatment.
Psychooncology. 2001. 10:156–165.
36. McDaniel JS, Musselman DL, Porter MR, Reed DA, Nemeroff
CB Depression in patients with cancer. Diagnosis, biology, and
treatment. Arch Gen Psychiatry. 1995. 52:89–99.
37. Zhu1 L, Ranchor A, Van der Lee M et al. Subtypes of depression in
cancer patients: an empirically driven Approach. Support Care
Cancer; 2016, 24:1387–1396.
38. Kelly CM, Juurlink DN, Gomes T, et al. Selective serotonin
reuptake inhibitors and breast cancer mortality in women
receiving tamoxifen: a population based cohort study. BMJ.
2010; 340:c693.
39. Cass-Verco J, Mason C, Wilcken N. Antidepressants and
tamoxifen: interaction concerns. Australas Psychiatry 2013 21:
508.
40. Phyllis Butow, Melanie A. Price, Joanne M. Shaw, Jane Turner,
Josephine M. Clayton, Peter Grimison, et al. Clinical pathway
for the screening, assessment and management of anxiety
and depression in adult cancer patients: Australian guidelines.
Psycho-Oncology; 2015,24: 987–1001.
41. Ostuzzi G, Matcham F, Dauchy S, Barbui C, Hotopf M.
Antidepressants for the treatment of depression in people with
cancer (Review). The Cochrane Library 2015, Issue.
[PSICOONCOLOGÍA EN EL HOSPITAL GENERAL. ALCANCES EN DEPRESIÓN Y CÁNCER - Dr. Octavio Rojas y cols.]